Exchange transfusion therapy in severe complicated malaria

Area of Science:

• Infectious Diseases
• Hematology
• Critical Care Medicine

Background:

• Severe falciparum malaria is a life-threatening condition with high mortality.
• Multisystemic complications are common in severe malaria, including central nervous system (CNS) involvement, acute renal failure (ARF), and pulmonary insufficiency.
• Exchange transfusion is a potential therapeutic option for managing severe malaria.

Purpose of the Study:

• To evaluate the efficacy of exchange transfusion in treating severe complicated falciparum malaria.
• To assess the impact of exchange transfusion on parasitemia and survival rates in patients with severe malaria.
• To identify specific complications where exchange transfusion may offer a survival benefit.

Main Methods:

• A retrospective study of nine patients with severe complicated falciparum malaria treated with exchange transfusion.
• Comparison of outcomes between exchanged patients and a matched group of non-exchanged patients.
• Analysis of parasitemia levels, systemic complications, and survival rates.

Main Results:

• Eight out of nine patients survived exchange transfusion therapy.
• Exchange transfusion rapidly decreased parasitemia to below 5% within 24 hours in most cases.
• While overall survival rates were similar between exchanged and non-exchanged groups, patients with ARDS showed a significantly higher survival rate (75% vs. 0%) after exchange transfusion.

Conclusions:

• Exchange transfusion is strongly recommended for severe falciparum malaria with parasitemia >30% and severe systemic complications, especially ARF or lung complications.
• A minimum of 1.2 times the blood volume should be used for exchange transfusion to effectively clear parasites and toxic metabolites.
• Exchange transfusion therapy offers a survival advantage in malaria patients with ARDS.